Kroon, F.P.

patient vaccination response vaccine study antibody rabie serum influenza hiv-infected patients titer level adomet hiv-infected b-d-glucan group immunization ph 1n count pneumocystis anti-rabie control result baseline schedule pneumonia signi diagnosis hepatitis effect virus ph 1n vaccine pneumocystis pneumonia infection s-adenosylmethionine 2009 pandemic influenza sample pandemic booster adult s-adenosylmethionine serum levels immunode pneumocystis carinii pneumonia ficiency value 2009–2010 fi ve patients population method 4 weeks igg 1 booster vaccination individual cells /mm seroprotection rate hiv-negative patients signi ficantly seroprotection analysis rabies vaccine treatment immunode ficiency erasmus university rotterdam avidity leiden university marker immunol neoantigen concentration university hiv-negative cross-reactive antibodies humoral range haart hepatitis b vaccination participant increase center igg subclasses